Preimplantation Genetic Testing Market Report Examines Latest Trends and Key Drivers Supporting Growth till 2022

Preimplantation genetic testing is done to find out specific genetic diseases within embryos. This testing is gaining lot of traction due to the increased risk of various diseases owing to the changing lifestyle. Various healthcare institutes, healthcare providers, and researchers are continuously researching on the preimplantation genetic testing to find new methods to eliminate various risks involved in preimplantation genetic diagnosis. Meanwhile, new technologies are also being developed to find all the possible genetic diseases and disorders. This FactMR report analyzes the expansion of global Preimplantation Genetic Testing Market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

The scope of FactMR’s report is to analyze the global Preimplantation Genetic Testing Market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global preimplantation genetic testing market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to preimplantation genetic testing.

Request a Free Sample Report Here – https://www.factmr.com/connectus/sample?flag=S&rep_id=292

Preimplantation genetic testing is the procedure of testing embryos to identify genetic diseases or defects before implantation. This test helps to implant healthy embryo which results in the genetically healthy baby. The test is done to eliminate the risk of structural chromosome abnormalities, Mendelian disorders, etc. However, preimplantation genetic testing also carries various risks such as multiple pregnancy, birth defects, ovarian hyperstimulation syndrome. Hence, researchers are focusing on developing new technology and methods that can minimize all the possible risks related with the preimplantation genetic testing.

Due to the changing lifestyle, increasing number of people are suffering from genetic disorders or diseases. Hence there has been a significant growth in the preimplantation genetic diagnosis. This test is also gaining traction to diagnose minor disabilities and other serious diseases such as cancer. Researchers are also focusing on using innovative techniques for eliminating the possibility of embryo destruction while preimplantation genetic testing.

According to the latest report by Fact.MR, the global market for preimplantation genetic testing is expected to experience strong growth. The market is estimated to reach US$ 575.0 million revenue by 2022 end. Due to the increasing awareness of preimplantation genetic testing to avoid genetic disorders, the rise in a number of healthcare providers and healthcare institutes providing preimplantation genetic testing are the influencing factors contributing to the tremendous growth of the preimplantation genetic testing across the globe.

View Full Report Here – https://www.factmr.com/report/292/preimplantation-genetic-testing-market

Embryo HLA typing for stem cell therapy is expected to show healthy growth from throughout 2017-2022. Embryo HLA typing for stem cell therapy is estimated to create an incremental opportunity exceeding US$ 70 million during 2017-2022.

NGS Technology to Gain Maximum Traction in the Preimplantation Genetic Testing Market

Compared to the various other technologies, NGS is expected to be the technology gaining highest revenue share in the global preimplantation genetic testing market. NGS is estimated to exceed US$ 200 million revenue by 2022 end.

Preimplantation Genetic Testing Market: Key Players

The report also profiles companies that are expected to remain active in the expansion of global preimplantation genetic testing market through 2022, which include Agilent Technologies Inc., Abbott Laboratories, CooperSurgical Inc., Oxford Gene Technology IP, Illumina, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Genea Limited, Natera, Inc., Rubicon Genomics, Inc., and CombiMatrix Corporation.

Table of Contents

1. Global Preimplantation Genetic Testing Market – Executive Summary
2. Global Preimplantation Genetic Testing Market Overview

2.1. Introduction

2.1.1. Global Preimplantation Genetic Testing Market Taxonomy

2.1.2. Global Preimplantation Genetic Testing Market Definition

2.2. Global Preimplantation Genetic Testing Market Size (US$ Mn) and Forecast, 2012-2022

2.2.1. Global Preimplantation Genetic Testing Market Y-o-Y Growth

2.3. Global Preimplantation Genetic Testing Market Dynamics

2.4. Supply Chain

2.5. Cost Structure

2.6. Pricing Analysis

2.7. Raw Material Sourcing Strategy and Analysis

2.8. Service Provider List

2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Preimplantation Genetic Testing Market Analysis and Forecast By Test Type

3.1. Global Preimplantation Genetic Testing Market Size and Forecast By Test Type, 2012-2022

3.1.1. Genetic Diagnosis Market Size and Forecast, 2012-2022

3.1.1.1. Revenue (US$ Mn) Comparison, By Region

3.1.1.2. Market Share Comparison, By Region

Continued………………………..

If You Need This Useful Report Then Buy This Report Here – https://www.factmr.com/checkout/292/S

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Sports market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us –

FactMR
Suite 9884
27 Upper Pembroke Street, Dublin 2, Ireland
Telephone @ +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/